Literature DB >> 17448647

When should the seminal vesicles be included in the target volume in prostate radiotherapy?

N A Bayman1, J P Wylie.   

Abstract

External beam radiotherapy to the prostate and seminal vesicles as a radical treatment for prostate cancer can result in a significant dose being delivered to the rectum. This can be reduced if the target volume includes the prostate only. Using a Medline search, published studies are reviewed to show that the risk of seminal vesicle involvement can be accurately predicted using readily available pre-treatment parameters. We recommend when to exclude the seminal vesicles from a target volume, and the proportion of seminal vesicles that should be included in a target volume in higher risk patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17448647     DOI: 10.1016/j.clon.2007.03.005

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  4 in total

Review 1.  Pictorial review. Magnetic resonance for radiotherapy management and treatment planning in prostatic carcinoma.

Authors:  Christopher Lim; Shawn C Malone; Leonard Avruch; Rodney H Breau; Trevor A Flood; Megan Lim; Christopher Morash; Jeff S Quon; Cynthia Walsh; Nicola Schieda
Journal:  Br J Radiol       Date:  2015-08-17       Impact factor: 3.039

2.  Optimal contouring of seminal vesicle for definitive radiotherapy of localized prostate cancer: comparison between EORTC prostate cancer radiotherapy guideline, RTOG0815 protocol and actual anatomy.

Authors:  Xin Qi; Xian-Shu Gao; Junichi Asaumi; Min Zhang; Hong-Zhen Li; Ming-Wei Ma; Bo Zhao; Fei-Yu Li; Dian Wang
Journal:  Radiat Oncol       Date:  2014-12-20       Impact factor: 3.481

3.  Seminal vesicle interfraction displacement and margins in image guided radiotherapy for prostate cancer.

Authors:  Daisy Mak; Suki Gill; Roxby Paul; Alison Stillie; Annette Haworth; Tomas Kron; Jim Cramb; Kellie Knight; Jessica Thomas; Gillian Duchesne; Farshad Foroudi
Journal:  Radiat Oncol       Date:  2012-08-13       Impact factor: 3.481

4.  Proctitis following stereotactic body radiation therapy for prostate cancer.

Authors:  Daniel Y Joh; Leonard N Chen; Gerald Porter; Aditi Bhagat; Sumit Sood; Joy S Kim; Rudy Moures; Thomas Yung; Siyuan Lei; Brian T Collins; Andrew W Ju; Simeng Suy; John Carroll; John H Lynch; Anatoly Dritschilo; Sean P Collins
Journal:  Radiat Oncol       Date:  2014-12-12       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.